Poverty and inequality in real-world schizophrenia: a national study.

Background: Schizophrenia has high socioeconomic impact among severe psychiatric disorders.

Aims: To explore clinician-reported and patient-reported inequities between patients under the poverty threshold vs. the others.

Microbiota-Orientated Treatments for Major Depression and Schizophrenia.

Background And Significance: There is a need to develop new hypothesis-driven treatment for both both major depression (MD) and schizophrenia in which the risk of depression is 5 times higher than the general population. Major depression has been also associated with poor illness outcomes including pain, metabolic disturbances, and less adherence. Conventional antidepressants are partly effective, and 44% of the subjects remain unremitted under treatment.